课题基金 / 基金详情

MICROGLIAL ACTIVATION PATHWAYS--REGULATION BY APOE

MICROGLIAL ACTIVATION PATHWAYS--REGULATION BY APOE
小胶质细胞激活途径——APOE 的调节
批准号:
2762233
负责人:
DANIEL T LASKOWITZ
金额:
$7.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2001-04-30

项目摘要

项目成果

DANIEL T LASKOWITZ的其他基金

相关文献

中文摘要
翻译
小胶质细胞的激活与大多数类型的神经病理有关, 最近的证据表明,小胶质细胞的激活可能在 导致某些神经元死亡。小胶质细胞激活导致脑血管内皮细胞死亡 神经元/神经胶质混合培养中神经元的选择性群体。这个 参与产生细胞毒素的小胶质细胞通路,尤其是 对于神经元的选择性,仍然没有得到充分的描述。酵母多糖,a 经典的吞噬巨噬细胞激活剂,是一种更具神经毒性的 小胶质细胞激活剂比脂多糖(LPS),一种可溶性内毒素 通常用于激活小胶质细胞。蛋白激酶C激活 似乎是酵母多糖相对的神经毒性增加的原因 致内毒素。载脂蛋白E(ApoE),一种神经胶质衍生因子,其 脑损伤后产量急剧增加,最近一直是 显示能抑制小胶质细胞的激活。人类apoE等位基因apoE4, 增加患阿尔茨海默氏症的风险 常见等位基因apo2和apoE3。越来越多的证据表明载脂蛋白E4 随着病情的加重和其他疾病预后的恶化 神经病理学也是如此。据报道,ApoE4的效果不如APOE2 或3抑制至少某些形式的小胶质细胞激活。我们 建议使用不表达载脂蛋白E的转基因小鼠的细胞培养, 小鼠载脂蛋白E、人载脂蛋白2、3或4研究载脂蛋白E的哪些步骤 抑制小胶质细胞的激活以及是否存在差异 人类载脂蛋白E亚型的作用。特别是,我们将确定 载脂蛋白E亚型是否优先抑制对可溶性或 吞噬细胞刺激,以及神经元特异性毒素的产生是否 选择性地被任何内源性产生的载脂蛋白E亚型抑制。
英文摘要
Microglial activation is associated with most types of neuropathology, and recent evidence suggests that microglial activation may contribute to death of certain neurons. Microglial activation leads to death of selective populations of neurons in mixed neuronal/glial cultures. The microglial pathways involved in producing cytotoxins, particularly ones selective for neurons, remain poorly characterized. Zymosan, a classical phagocytosed macrophage activator, is a more neurotoxic microglial activator than lipopolysaccharide (LPS), a soluble endotoxin commonly used to activate microglia. Protein kinase C activation appears to account for the increased neurotoxicity of zymosan relative to LPS. Apolipoprotein E (apoE), a glial derived factor whose production increases dramatically after brain injury, has recently been shown to suppress microglial activation. One human apoE allele, apoE4, increases the risk of developing Alzheimers Disease relative to the more common alleles apoE2 and apoE3. Increasing evidence implicates apoE4 as increasing severity and worsening prognosis for other neuropathologies as well. ApoE4 is reportedly less effective than apoE2 or 3 at suppressing at least some forms of microglial activation. We propose to use cell cultures from transgenic mice expressing no apoE, murine apoE, human apoE2, 3 or 4 to investigate at which steps apoE inhibits microglial activation and whether there is a differential effect of the human apoE isoforms. In particular, we will determine whether apoE isoforms preferentially inhibit responses to soluble or phagocytosed stimuli, and whether neuron-specific toxin production is selectively inhibited by any of the endogenously produced apoE isoforms.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Training for the Prevention and Treatment of Stroke in China
  • 批准号:
    8690195
  • 项目类别:
  • 资助金额:
    $13.79万
  • 财政年份:
    2010
  • 负责人:
    DANIEL T LASKOWITZ
  • 依托单位:
Training for the Prevention and Treatment of Stroke in China
  • 批准号:
    8094299
  • 项目类别:
  • 资助金额:
    $14.22万
  • 财政年份:
    2010
  • 负责人:
    DANIEL T LASKOWITZ
  • 依托单位:
Training for the Prevention and Treatment of Stroke in China
  • 批准号:
    8508326
  • 项目类别:
  • 资助金额:
    $13.51万
  • 财政年份:
    2010
  • 负责人:
    DANIEL T LASKOWITZ
  • 依托单位:
Training for the Prevention and Treatment of Stroke in China
  • 批准号:
    7944954
  • 项目类别:
  • 资助金额:
    $14.55万
  • 财政年份:
    2010
  • 负责人:
    DANIEL T LASKOWITZ
  • 依托单位: